|
|
ADHD in Women: A Neuroendocrine Lens on a Neurodevelopmental Disorder
|
|
By Ruth Hobson, ND | June 25, 2025
|
Attention Deficit Hyperactivity Disorder (ADHD) is a well-established neurodevelopmental condition characterized by disruptions in attention regulation, impulsivity, and executive function. It is strongly associated with dopaminergic dysregulation, particularly in the prefrontal cortex. While ADHD is often identified in boys during childhood, it is increasingly clear that females are significantly underdiagnosed, often presenting later in life with a more internalized symptom profile. One key reason? The underappreciated role of hormonal fluctuations in shaping symptom expression across the female lifespan.
Estrogen and progesterone are not only reproductive hormones; they are also potent neuromodulators. Estrogen enhances dopaminergic signaling, improves synaptic plasticity, and supports emotional regulation and working memory. Conversely, progesterone has been shown to attenuate some of these benefits, potentially blunting dopamine activity and exacerbating ADHD symptoms. Throughout the menstrual cycle, these hormones fluctuate. Estrogen dominance during the follicular phase may improve ADHD symptoms, while progesterone's rise during the luteal phase often corresponds with worsening mood, focus, and impulse control. This cyclical pattern may go unrecognized in clinical practice, particularly if providers do not routinely consider the neuroendocrine connection of cognitive or emotional complaints in women and girls.
When ADHD May Surface or Worsen
-
Adolescence: The initiation of cyclic hormonal activity can trigger increased emotional sensitivity, distractibility, or anxiety often misinterpreted as typical teenage behavior or mood instability.
-
Reproductive years: Many women remain undiagnosed until adulthood, when the cumulative demands of work, relationships, and parenting overwhelm prior compensatory strategies. In many cases, a child’s diagnosis prompts a retrospective recognition in the mother.
-
Pregnancy and postpartum: While elevated estrogen during pregnancy may transiently buffer symptoms, the dramatic postpartum drop in estrogen and dopamine is associated with decreased executive dysfunction, overwhelm, and mood disturbances. These are frequently misdiagnosed as postpartum depression, though they may reflect underlying ADHD.
-
Perimenopause and menopause: This transition is often the tipping point for women who have struggled silently for decades. As estrogen levels decline, dopamine signaling weakens, and previously manageable ADHD symptoms may become heightened. Many women receive their first ADHD diagnosis during this phase.
Due to the established neuroendocrine influence of ADHD, treatment strategies that support hormonal balance, dopaminergic tone, and HPA axis regulation can offer a more comprehensive and personalized approach to symptom management.
Enhancing dopamine synthesis and signaling is often foundational. Nutrients such as L-tyrosine, a dopamine precursor, may improve cognitive performance and motivation, especially under stress, and are often found to be depleted in individuals with ADHD. Omega-3 fatty acids, particularly EPA, have demonstrated efficacy in improving attention and reducing hyperactivity in both pediatric and adult populations by modulating neuroinflammation and promoting neuronal membrane fluidity.
To further support cognitive performance and HPA-axis resilience, adaptogenic herbs such as Rhodiola rosea and Panax ginseng may reduce mental fatigue, enhance prefrontal cortex function, and increase dopamine receptor sensitivity indirectly improving attention and emotional regulation. For individuals with hormonally sensitive symptom patterns, bioidentical hormone therapy, including estradiol and progesterone, may help stabilize estrogen levels and reduce the cyclical exacerbation of ADHD symptoms commonly seen in women.
Finally, lifestyle and mind-body interventions, including aerobic exercise, mindfulness-based stress reduction, and sleep optimization play a vital role in supporting HPA axis function. These practices not only reduce cortisol dysregulation and enhance dopamine availability but also buffer against stress-induced worsening of symptoms and improve overall executive functioning
To further individualize care, the NeuroHormone Complete Plus Profile offers a comprehensive analysis of estrogen, progesterone, cortisol, and key neurotransmitters providing critical insights into the neuroendocrine drivers of ADHD in women.
|
|
|
|
|
|
|
References
-
Arnsten AFT. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex. J Pediatr. 2009;154(5):I–S43. doi:10.1016/j.jpeds.2009.01.018
-
Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R. Hormonal fluctuations and neuropsychiatric conditions. Nat Rev Endocrinol. 2020;16(8):471-484. doi:10.1038/s41574-020-0371-6
-
Chang JP-C, Su KP, Mondelli V, et al. Omega-3 polyunsaturated fatty acids in ADHD: A meta-analysis of randomized controlled trials. Nutrients. 2018;10(2):193. doi:10.3390/nu10020193
-
Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord. 2002;5(3):143-154. doi:10.1177/108705470200500302
-
Mitchell JT, Zylowska L, Kollins SH. Mindfulness meditation training for attention-deficit/hyperactivity disorder in adulthood: Current empirical support, treatment overview, and future directions. Cogn Behav Pract. 2015;22(2):172-191. doi:10.1016/j.cbpra.2014.10.002
-
National Institute of Mental Health. Attention-Deficit/Hyperactivity Disorder (ADHD). U.S. Department of Health and Human Services. Published October 2023. Accessed June 23, 2025. https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
-
Nussbaum NL. ADHD and female specific concerns: A review of the literature and clinical implications. J Atten Disord. 2012;16(2):87-100. doi:10.1177/1087054710381483
-
Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals. 2010;3(1):188-224. doi:10.3390/ph3010188
-
Pletzer B, Kronbichler M, Nuerk HC, Kerschbaum HH. Menstrual cycle variations in cognitive and emotional function. Horm Behav. 2010;58(2):297-307. doi:10.1016/j.yhbeh.2010.03.005
-
Pontifex MB, Saliba BJ, Raine LB, Picchietti DL, Hillman CH. Exercise improves behavioral, neurocognitive, and scholastic performance in children with attention-deficit/hyperactivity disorder. J Pediatr. 2013;162(3):543-551. doi:10.1016/j.jpeds.2012.08.036
-
Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls: Uncovering this hidden diagnosis. Prim Care Companion CNS Disord. 2014;16(3). doi:10.4088/PCC.13r01596
-
Rao TS, Asha MR, Ramesh BN, Jagannatha Rao KS. Understanding nutrition, depression and mental illnesses. Indian J Psychiatry. 2008;50(2):77-82. doi:10.4103/0019-5545.42391
-
Sangal RB, Sangal JM. Effects of estrogen and progesterone replacement on attention in menopausal women with attention deficit hyperactivity disorder. J Womens Health. 2005;14(5):463-467. doi:10.1089/jwh.2005.14.463
-
Slykerman RF, Coomarasamy C, Wickens K, et al. The microbiome and neurodevelopmental disorders: A review. Nutrients. 2019;11(6):1458. doi:10.3390/nu11061458
-
Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with ADHD. Magnes Res. 1997;10(2):149-156.
-
Williamson D, Johnston C. Gender differences in ADHD: A meta-analysis and critical review. Clin Psychol Rev. 2015;40:15-27. doi:10.1016/j.cpr.2015.05.007
|
|
|
|
|
|
|
|
Methylation and Clinical Practice: Insights from the Doctor's Data Methylation Profile
Presented by Julia Malkowski, ND, DC | July 2, 2025 at 12 PM Pacific
|
|
|
|
|
|
|
Methylation is a fundamental biochemical process with far-reaching implications for human health. This presentation will offer an in-depth exploration of methylation, its clinical significance, and the impact of methylation imbalances on health outcomes.
Methylation is involved in cardiovascular health, detoxification, neurotransmitter synthesis, hormone metabolism, DNA expression, immune modulation and fetal development. Analyzing key methylation biomarkers provides valuable insight into human physiology. Plasma levels of methionine, s-Adenosyl methionine (SAM), s-Adenosyl homocysteine (SAH), homocysteine, cystathionine and cysteine provide a functional assessment of the methylation cycle. Attendees will walk away with an understating of these biomarkers, enhanced understanding of methylation dynamics and their impact on clinical outcomes.
|
Learning Objectives:
-
Understand the role of methylation in human physiology
-
Comprehend objective biomarkers of the methylation cycle, including the methylation ratio, methionine, SAM, SAH, homocysteine, cystathionine and cysteine
-
Explore the clinical significance of methylation imbalances
-
Discuss case applications and therapeutic strategies based on methylation status
|
|
|
|
|
|
|
|
Nutrient Depletion and Mental Wellness
Presented by Krista Anderson Ross, ND | July 9, 2025 at 11:00 AM Pacific
|
|
|
|
|
|
|
Many people experience shifts in nutrient levels due to lifestyle habits, dietary choices, or long term physical and emotional stress. These changes may influence how the body supports cellular energy, maintains a balanced mood, and handles daily mental demands.
In this educational session, Dr. Krista Anderson-Ross, a naturopathic physician with over 20 years of clinical experience and expertise in functional lab testing, will explore how key nutrients including B vitamins, magnesium, zinc, and CoQ10 can help support healthy brain function and cellular energy processes. She will discuss how nutrient depletion may affect energy levels, oxidative balance, and emotional well being, and how personalized nutrition strategies may help promote overall mental resilience.
|
Learning Objectives:
-
Discover how nutrient patterns may influence mitochondrial and cognitive function
-
Learn about essential nutrients that can support mental focus and emotional well being
-
Explore how functional testing tools like neurotransmitter panels and methylation profiles can offer insights for personalized wellness planning
This event is hosted by Rupa University, a Fullscript company.
|
|
|
|
|
|
|
|
Lab Essentials Bootcamp - GI360™ Stool Test from Doctor's Data: Assess Digestive Function, Microbiome and More
Starts July 21, 2025
|
|
|
|
|
|
|
Join Lylen Ferris, ND, Julia Malkowski, ND, DC, Jeannie Gorman, MS, CCN, and Laura Neville, ND for a 6-week immersive bootcamp designed to help you master the GI360™ test-combining advanced microbiome analysis with comprehensive digestive function assessment.
This bootcamp offers a clinical deep dive into interpreting commensals, pathogens, and biomarkers of digestion, inflammation, and immune activation-translating lab data into targeted, root-cause treatment strategies for GI-driven chronic conditions.
|
Learning Objectives:
-
Comprehensive interpretation strategies for GI360™ results-including microbiome diversity, pathogenic bacteria, dysbiosis patterns, and digestive function markers (e.g., elastase, SCFAs, steatocrit).
-
Root-cause connections between GI findings and systemic conditions like autoimmunity, metabolic dysfunction, and neuroinflammation.
-
Evidence-based protocols for addressing bacterial overgrowth, enzyme insufficiencies, leaky gut, and immune dysregulation using diet, botanicals, and targeted supplementation.
-
Case-based guidance on integrating GI360™ insights into personalized treatment plans, progress tracking, and long-term gut healing strategies.
-
Engage in 6 live Q&A sessions with the Doctor's Data team!
The first live session is on Thursday, July 24th, 2025. We hope to see you there!
This event is hosted by Rupa University, a Fullscript company.
|
|
|
|
|
|
|
|
Taming a Runaway Immune System: Auto-immunity and The Microbiome
Presented by Cheryl Burdette, ND | July 23, 2025 at 12 PM Pacific
|
|
|
|
|
|
|
Our understanding of immunotolerance and autoimmunity, through gut-based exposure, has grown exponentially over the years. This broadened understanding of gut based immune priming elucidates new targets for immune regulation in autoimmune conditions. As our understanding of the microbiome increases, we can understand the mechanisms that skew and support immune tolerance and T-cell differentiation. A key regulator in many autoimmune conditions includes the interaction between Lipopolysaccharide (LPS), a bacterial endotoxin, and Treg cells. Although LPS is ubiquitous to Gram-negative bacteria, and created by several commensal bacterial Genera, immune regulation to LPS also involves the interaction of Gram-positive flora such as Bifidobacter. These interactions will determine programming of naive T-cells and influence the balance of the immune response. We will also look at the wealth of research around other analytes related to autoimmunity such as short chained fatty acids, particular species and interventions to change them. Review of the microbiome and its activity in immune function increases our clinical understanding and management of autoimmune conditions such as Rheumatoid arthritis, and Crohn's Disease, to name a few.
|
|
|
|
|
|
|
Disclaimer: All information given about health conditions, treatment, products, and dosages are for educational purposes only and do not constitute medical advice.
|
|
|
|
|
|
|
800.323.2784 (US and Canada)
+1.630.377.8139 (Global)
|
|
|
|
|
|
